Essilor is a global leader in the ophthalmic optics market, with a market cap of around $64 billion. The company designs, manufactures and markets lenses to correct or protect eyesight and is the world's largest manufacturer of ophthalmic lenses. Its activities are largely focused on research and development. Essilor has around 70,000 employees with 32 plants and 14 distribution centers worldwide and a footprint in over 100 countries.
Tobii is the global leader in eye tracking and operates through its three business units: Tobii Dynavox - makes specially designed computers that are controlled by eye movement for use by people with special needs. Tobii Pro - sells eye-tracking equipment used today by more than 3,500 companies and 2,500 research institutions. Tobii Tech - develops Tobii’s technology for new volume markets, such as computer games, personal computers, virtual and augmented reality, healthcare and industrial applications.
Founded in 2016, Rimonci firmly focuses on vertical fields and engages in a superbly operated VC mode. Its first fund, “Rimonci Global Vision Science Fund”, centers around visual science including the ophthalmology, optometry and neuro-ophthalmology fields mainly in America, Israel, Europe and Greater China. With the motto “For Better Vision and Insight”, closely integrating healthcare and IT and with an in-depth industrial understanding and abundant operation and management experience, Rimonci follows the philosophy of “Consult, Connect and Conduct” to help drive its portfolio companies to success through the elaborately established industry ecosystem.
Club 100 Plus, a private investors club, enables its members to create diversified investments portfolios tailored to each member’s personal preferences, with relatively small investment amounts and with a high probability of success relative to the risk involved. Operating since 2011, the Club has thus far made over 50 investments. The Club has a collaboration agreement with the world’s largest private investment network, Keiertsu Forum, headquartered in the United States.
The Israel Innovation Authority, part of Israel's Ministry of Economy, is the Israeli government’s support arm, charged with fostering the development of industrial R&D within the State of Israel. The Authority’s operations are facilitated through a variety of international programs, agreements and collaborations. Its mission is to assist the advancement of Israel's knowledge-based science and technology industries in order to encourage innovation and entrepreneurship while stimulating economic growth. The Innovation Authority has issued 3 grants to NovaSight, totaling $1 million.